CRONOS GROUP INC. Financial Assets At Fair Value Through Other Comprehensive Income
CRONOS GROUP INC. (CRON) had Financial Assets At Fair Value Through Other Comprehensive Income of CAD 705.00 thousand as of 2018-12-31, per its 40-F filed 2019-03-26.
Discontinued › Notes › Equity
ifrs-full:FinancialAssetsAtFairValueThroughOtherComprehensiveIncome · last filed 2019-03-26
- 2018-12-31: Financial Assets At Fair Value Through Other Comprehensive Income 705.00K CAD.
- 2017-12-31: Financial Assets At Fair Value Through Other Comprehensive Income 1.18M CAD.
| Period end | Financial Assets At Fair Value Through Other Comprehensive Income |
|---|---|
| 2018-12-31 | 705.00K CAD 40-F · filed 2019-03-26 |
| 2017-12-31 | 1.18M CAD 40-F · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |